Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Global antibiotic shortages, caused by a fragile drug supply chain, are contributing to the rise of multidrug-resistant bacteria known as superbugs, according to a report from the Access to Medicine Foundation.
President Donald Trump expects pharmaceutical companies to significantly lower drug prices over the next few weeks, according to Reuters.
How Boston-based Massachusetts General Hospital is dealing with the ongoing intravenous opioid shortage most captured readers' attention in May.
The FDA approved TherapeuticsMD's hormone therapy Imvexxy for a vaginal condition linked to low estrogen levels during menopause, the company announced May 30.
Actress Roseanne Barr claims her controversial tweet about Valerie Jarrett, a White House aide during the Obama administration, was due to her taking Sanofi's insomnia drug Ambien, reports CNN.
Amazon on May 29 earned a patent outlining the various methods its delivery drones could use to signal their approach and interact with customers expecting packages, reports GeekWire.
The drugmaker Allergan issued a voluntary recall of nearly 170,000 Taytulla birth control sample packs after placebo pills and active capsules were placed in the wrong order, an error that could raise the risk of unintended pregnancy.
Fortune has unveiled its 64th annual list of the 500 most profitable American companies, which amassed up to $12.8 trillion in revenues in the last year.
After a strategic review, Allergan plans to sell its multibillion dollar women's health and infectious disease units, according to CNBC.
The FDA approved an artificial intelligence algorithm designed to help physicians detect wrist fractures May 24.